Literature DB >> 33624013

Cytomorphologic Features Found in Cerebrospinal Fluid Specimens of Hemophagocytic Lymphohistiocytosis Patients.

Susan Shyu1, Dragos Luca2, Christopher J VandenBussche3, Cheng-Ying Ho1,4.   

Abstract

OBJECTIVES: Central nervous system involvement is present in 70% of patients with hemophagocytic lymphohistiocytosis (CNS-HLH). CNS-HLH is defined by neurologic deficits, neuroimaging abnormalities, or positive cerebrospinal fluid (CSF) findings. The CSF cytomorphologic spectrum of CNS-HLH, however, has not been well investigated.
METHODS: A retrospective review was performed on 64 CSF specimens from pediatric and adult patients with HLH. Ten patients had clinicoradiologic evidence of CNS involvement.
RESULTS: We identified five CSF cytomorphologic patterns: (1) hemophagocytosis, (2) vacuolated macrophages without evidence of hemophagocytosis, (3) monocytes and/or nonvacuolated macrophages, (4) acellular specimens, and (5) bloody specimens. Patterns 1 and 2 were common in CNS-HLH and rare in patients without CNS involvement. The CSF cytomorphologic patterns did not correlate well with WBC counts or protein concentration.
CONCLUSIONS: Our study offers a comprehensive view of the cytomorphologic features seen in CSF specimens from patients with HLH. © American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cerebrospinal fluid; Cytology; Hemophagocytic lymphohistiocytosis

Mesh:

Year:  2021        PMID: 33624013      PMCID: PMC8336598          DOI: 10.1093/ajcp/aqaa248

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  28 in total

Review 1.  Comparing hemophagocytic lymphohistiocytosis in pediatric and adult patients.

Authors:  Christian A Wysocki
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-12

2.  Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes.

Authors:  D M Komp; J McNamara; P Buckley
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

3.  Fat-laden macrophages in cerebrospinal fluid as an indication of brain damage in children.

Authors:  D C Chester; J L Emery; S R Penny
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791

4.  Neonatal CSF cytology.

Authors:  B Dalens
Journal:  Am J Dis Child       Date:  1983-01

5.  Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; I Nennesmo
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

6.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.

Authors:  Helena Trottestam; Annacarin Horne; Maurizio Aricò; R Maarten Egeler; Alexandra H Filipovich; Helmut Gadner; Shinsaku Imashuku; Stephan Ladisch; David Webb; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

7.  Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups.

Authors:  D Zeman; P Adam; H Kalistová; O Sobek; J Andĕl; M Andĕl
Journal:  Acta Cytol       Date:  2001 Jan-Feb       Impact factor: 2.319

8.  Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis.

Authors:  L Táborský; P Adam; O Sobek; M Dostál; J Dvoráková; L Dubská
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

9.  Cytologic features of cerebrospinal fluid in Lyme disease.

Authors:  F Razavi-Encha; J Fleury-Feith; R Gherardi; J F Bernaudin
Journal:  Acta Cytol       Date:  1987 Jul-Aug       Impact factor: 2.319

Review 10.  How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis?

Authors:  AnnaCarin Horne; Ronny Wickström; Michael B Jordan; E Ann Yeh; Ahmed Naqvi; Jan-Inge Henter; Gritta Janka
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.